Agenda
Detailed agenda TBA. Please check back soon!
Keynote Speakers

Swiss Federal Institute of Technology Lausanne (EFPL), Switzerland, Inst. of Cancer Research, London, UK

Dana-Farber Cancer Institute
Boston, MA, USA
Confirmed Speakers & Chairs

University of Edinburgh, Scotland

European Institute of Oncology, University of Milan, Italy

University of Utah
Salt Lake City, UT, USA

Weill Cornell Med./New York-Presbyterian Hosp., NY, USA

Fred Hutchinson Cancer Center, Seattle, WA, USA

UMC Utrecht,
Netherlands

Katholieke Universiteit Leuven,
Leuven, Belgium

Lobular Breast Cancer Ireland

Katholieke Universiteit Leuven,
Leuven, Belgium

University of Pittsburgh, Pittsburgh, PA, US

University of Texas Southwestern,
Dallas, TX, USA

Dana-Farber Cancer Institute,
Boston, USA

Charité-Universitätsmedizin, Berlin, Germany

UMC Utrecht,
Netherlands

Institute for Precision Medicine, University of Pittsburgh & UPMC, Pittsburgh, PA, USA

Fred Hutchinson Cancer Center,
Seattle, WA, USA

Dana-Farber Cancer Institute,
Boston, MA, USA

University of Texas MD Anderson Cancer Center,
Houston, TX, USA

UPMC Hillman Cancer Center; Magee-Womens Research Institute, Pittsburgh, PA, USA

Independent ILC advocate; Breast Cancer Care & Research Fund (BCCRF)

Memorial Sloan Kettering Cancer Center, NY, USA

University of Colorado Denver, Anschutz Medical Campus,
Denver, CO, USA

Foundation Medicine,
Boston, USA

Lobular Breast Cancer UK (LBCUK)

Hoag Family Cancer Institute, University of Southern, California, USA

Katholieke Universiteit Leuven,
Leuven, Belgium

Memorial Sloan Kettering Cancer Center,
NYC, NY, USA

Royal College of Surgeons in Ireland (RCSI),
Dublin, Ireland

Dwek Inst. for Cancer Therapy Research, Weizmann Institute of Science, Rehovot, Israel